Study Investigating the Impact Burden of Nocturia Using the Nocturia Impact Diary

PHASE3CompletedINTERVENTIONAL
Enrollment

56

Participants

Timeline

Start Date

March 31, 2012

Primary Completion Date

May 31, 2012

Study Completion Date

June 30, 2012

Conditions
Nocturia
Interventions
DRUG

Desmopressin

Desmopressin orally disintegrating tablets. Female participants took a 25 μg tablet and male participants took a 75 μg tablet one hour prior to bedtime for one month.

DRUG

Placebo

Placebo to match the 25 μg tablet of active drug taken by female participants or the 75 μg tablet taken by males. One placebo tablet taken one hour prior to bedtime for one month.

Trial Locations (10)

Unknown

South Florida Medical Research, Aventura

Avail Clinical Research, LLC, DeLand

Accelovance, Peoria

DM Clinical Research, Springfield

Beyer Research, Kalamazoo

Remedica LLC, Rochester

Accumed Research Associates, Garden City

Radiant Research, Inc., Greer

Quality Research, Inc., San Antonio

Radiant Research, Inc., San Antonio

Sponsors
All Listed Sponsors
lead

Ferring Pharmaceuticals

INDUSTRY